Your browser doesn't support javascript.
loading
Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Laszlo, George S; Alonzo, Todd A; Gudgeon, Chelsea J; Harrington, Kimberly H; Kentsis, Alex; Gerbing, Robert B; Wang, Yi-Cheng; Ries, Rhonda E; Raimondi, Susana C; Hirsch, Betsy A; Gamis, Alan S; Meshinchi, Soheil; Walter, Roland B.
Afiliação
  • Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
  • Alonzo TA; Department of Biostatistics, University of Southern California, Los Angeles, CA, USA.
  • Gudgeon CJ; Children's Oncology Group, Monrovia, CA, USA.
  • Harrington KH; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
  • Kentsis A; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
  • Gerbing RB; Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY, USA.
  • Wang YC; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ries RE; Weill Medical College of Cornell University, New York, NY, USA.
  • Raimondi SC; Children's Oncology Group, Monrovia, CA, USA.
  • Hirsch BA; Children's Oncology Group, Monrovia, CA, USA.
  • Gamis AS; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA.
  • Meshinchi S; Children's Oncology Group, Monrovia, CA, USA.
  • Walter RB; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
J Hematol Oncol ; 9(1): 133, 2016 11 30.
Article em En | MEDLINE | ID: mdl-27903291

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido